Up next
Share article
The post has been shared by 0 people.
Mail 0
LinkedIn 0
Twitter 0

Global API Outlook: Will Supply Lines Change Amid Tariff Uncertainty? 

As evolving US trade policy looms, what are the demand–supply fundamentals now in the global market for active pharmaceutical ingredients (APIs)?  A look at the demand side—size, growth rates, and trends— and the supply side—key segments for global API manufacturing and its geographic dispersion. Plus, examining the impact of potential tariffs on manufacturing and supply chains.  

Julia Morilla, Associate Content Analyst, Cortellis Product Intelligence, Clarivate

Featuring Julia Morilla, Associate Content Analyst, Cortellis Product Intelligence, Clarivate, a business intelligence firm serving the life sciences and bio/pharmaceutical industries.

Each episode of the Production to Prescription podcast is housed on the DCAT Value Chain Insights website and also delivered through DCAT Value Chain Insights weekly email digest. Not a subscriber? Click here to subscribe to DCAT Value Chain Insights. Or get each episode through:

For a full list of the 2025 podcast episode schedule, click here.

You May Also Like

Biomanufacturing: How are Industry Capacity & Supply Chains Trending?

By
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies, and is there too much capacity or is the market tight? Is biomanufacturing outsourcing…

Parenteral Drug Manufacturing—CDMO Outlook: A Capacity Crunch or Easing?

By
What is the supply and demand outlook for fill–finish capacity in the CDMO/CMO sector? Is a capacity crunch or capacity ease in the making? And how will hot-product areas, such…

Bio/Pharma Industry Outlook, Supply Chains 2025: The Year Ahead

By
What will be the key issues shaping bio/pharma supply chains in 2025? Looking at the impact of potential changes in US tariff and trade policy. Plus, what lies ahead in…